MGMT expression and its relationship with efficacy of chemotherapy and prognosis in patients with non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 6, Issue 1, 2003, Pages 63-66

  Lu, Jinfang ^a   Liu, Ru ^b   Li, Bin ^b   Qiu, Xueshan ^b   Li, Qingchang ^b   Wang, Enhua ^b  

^a Anshan the 4th Hospital   (China)

^b NONE

Author keywords

Chemotherapy; MGMT; NSCLC

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DNA; DOXORUBICIN; ETOPOSIDE; MESSENGER RNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DNA REPAIR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0037327901     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Belanich M, Randall T, Pastor MA, et al. Intracellular localization and intercellular heterogeneity of the human DNA repair protein O (6)-methylguanine-DNA methyltransferase. Cancer Chemother Pharmacol, 1996, 37(6): 547-555.
2. Citron M, Decker R, Chen S, et al. O6-methylguanine-DNA methyltransferase in human normal and tumour tissues from brain, lung, and ovary. Cancer Res, 1991, 51(6): 4131-4134.
3. Mattern J, Bak M, Hahn EW, et al. Human tumor xenografts as model for drug testing. Cancer Metastasis Rev, 1988, 7(3): 263-284.
4. Citron M, Graver M, Schoenhaus M, et al. Detection of messen-ger RNA from O6-methylguanine-DNA methyltransferase gene MGMT in human normal and tumor tissues. J Natl Cancer Inst, 1992, 84(5): 337-340.
5. Mattern J, Eichhorn U, Kaina B, et al. O6-methylguanine-DNA-methyltransferase activity and sensitivity to cyclophosphamide and cisplatin in human lung tumor xenografts. Int J Cancer, 1998, 77(6): 919-922.
6. Lee SM, Crowther D, Scarffe JH, et al. Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation. Br J Cancer, 1992, 66(2): 331-336.